SUMMARY OF PRODUCT CHARACTERISTICS TEMPLATE FOR Applicants
SUMMARY OF PRODUCT CHARACTERISTICS TEMPLATE FOR Applicants
PATIENT INFORMATION LEAFLET (PIL)TEMPLATE FOR Applicants
PATIENT INFORMATION LEAFLET (PIL)TEMPLATE FOR Applicants
GUIDELINE FOR PREPARATION AND PUBLICATION OF PUBLIC ASSESSMENT REPORTS FOR APPROVED MEDICINES
GUIDELINE FOR PREPARATION AND PUBLICATION OF PUBLIC ASSESSMENT REPORTS FOR APPROVED MEDICINES
Rosutrox 5 mg, 10 mg, 20 mg and 40 mg film coated tablets_SUMMARY OF PRODUCT CHARACTERISTICS
Rosutrox 5 mg, 10 mg, 20 mg and 40 mg film coated tablets_SUMMARY OF PRODUCT CHARACTERISTICS
Rosutrox 5 mg, 10 mg, 20 mg and 40 mg film coated tablets _ Public assessment summary report_Package label
Rosutrox 5 mg, 10 mg, 20 mg and 40 mg film coated tablets _ Public assessment summary report_Package label
PASURTA (erenumab) 140 mg per mL _ SUMMARY OF PRODUCT CHARACTERISTICS
PASURTA (erenumab) 140 mg per mL _ SUMMARY OF PRODUCT CHARACTERISTICS
PASURTA (erenumab) 140 mg per mL _ Public assessment summary report_Package label
PASURTA (erenumab) 140 mg per mL _ Public assessment summary report_Package label
Magnesium sulfate-Kalceks 500 mg per ml solution for injection_SUMMARY OF PRODUCT CHARACTERISTICS
Magnesium sulfate-Kalceks 500 mg per ml solution for injection_SUMMARY OF PRODUCT CHARACTERISTICS
Magnesium sulfate-Kalceks 500 mg per ml solution for injection_ Public assessment summary report_Package label
Magnesium sulfate-Kalceks 500 mg per ml solution for injection_ Public assessment summary report_Package label
OCTANATE 500 and OCTANATE 1000 _SUMMARY OF PRODUCT CHARACTERISTICS
OCTANATE 500 and OCTANATE 1000 _SUMMARY OF PRODUCT CHARACTERISTICS